GSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid what a spokesperson said is ...

GSK has delivered a solid multi year share price run, helped by fresh moves in oncology and vaccines, and that raises a ...

GSK plc’s GSK Specialty Medicines business has become the company’s most important growth engine. The segment includes HIV, ...

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once again. GSK now expects to generate more than 40 billion pound sterling ($50 ...

Key Points Interested in GSK PLC Sponsored ADR? Here are five stocks we like better. GSK is expanding oncology across lung, ...

GSK committed $270 million up front in recent months to gain access to early-stage assets in the class of cancer therapies known as antibody drug conjugates, or ADCs. The deals are part of a broad ...

GSK stock increased 0.4% following Berenberg's upgrade to buy with £22 target and announcement of $750M Chimagen deal for multiple myeloma therapy.

Sixteen organizations, awarded funding in 2025, are taking innovative, local approaches to boosting vaccination in communities across the US Grant recipients’ projects aim to modernize outreach ...

Sept 28 - GSK GSK.L on Thursday lifted its medium-term growth forecast for its HIV drugs business ViiV, encouraged by strong sales of long-acting injections that aim to replace daily pills for ...

Chinese police alleged GSK funneled money through travel agencies to bribe doctors and hospital officials, triggering parallel investigations and severe operational and financial impacts, including a ...

Sept 28 - GSK GSK.L on Thursday lifted its medium-term growth forecast for its HIV drugs business ViiV, encouraged by strong sales of long-acting injections that aim to replace daily pills for ...